Anthem Biosciences IPO open date is July 14 and IPO closing date is July 16, 2025. This new IPO is a book-built issue of up to 5,95,61,404 equity shares, worth up to Rs 3,395 crore. This upcoming IPO is offering an entirely offer for sale.
Anthem Biosciences IPO price band is Rs 540 to Rs 570 per share. As of now, Anthem Biosciences IPO GMP Live is at Rs 133. Live IPO Grey Market Premium details is visible online.
Anthem Biosciences IPO allotment status is finalised on July 17, 2025. The lot size is 26 shares. The minimum investment for retail investors is 1 lot, amounting to Rs 14,820. The registrar for Anthem Biosciences IPO is Kfin Technologies Limited. The listing date is July 21, 2025.
Also Read | Gem Aromatics IPO GMP, Open Date, Price Band, DRHP Filed
Anthem Biosciences IPO GMP
Anthem Biosciences IPO GMP is at Rs 133 per share. The IPO GMP today indicates the interest of retail investors in the IPO. You can check the latest IPO Grey Market Premium today online from the first day of subscription. If the subscription is oversubscribed, then Anthem Biosciences IPO GMP might rise in the coming days.
Anthem Biosciences IPO GMP Live status will indirectly impact the sentiments of the IPO investors. If the Grey Market Premium is quoting at 10% or above, then the possibility of the oversubscription increases.
However, if the Live IPO GMP quotes are 10% or below the premium, then most investors tend to lose interest in applying for the IPO and the probability of the under-subscription increases. Here, in the Anthem Biosciences IPO, GMP is expected to quote the initial ticks at a premium of 16% or above.
Anthem Biosciences IPO Open Date, Close Date
Anthem Biosciences IPO's open date is July 14 and IPO closing date is July 16, 2025. The allotment status date is available on July 17, 2025 and credit of shares to demat and initiation of refunds will be on July 18, 2025.
Anthem Biosciences IPO Price Band
Anthem Biosciences IPO price band is Rs 540 - Rs 570. The minimum amount of investment for the retail category is to be around Rs 14,820, and for small HNI, the minimum investment will be around Rs 2,07,480.
Anthem Biosciences IPO Issue Size
Anthem Biosciences IPO issue size is of 5,95,61,404 equity shares worth up to Rs 3,395 crore, entirely as an Offer for Sale; there will be no fresh issue part included in this IPO.
Anthem Biosciences IPO Allotment Status
Anthem Biosciences IPO allotment status is available on July 17, 2025. The listing will be on the BSE and NSE platforms. The registrar of this IPO is KFin Technologies Limited. Investors can check their allotment status after the subscription of the IPO ends.
Anthem Biosciences IPO Listing Date
Anthem Biosciences IPO's listing date is July 21, 2025. The listing will be on BSE and NSE platforms. Retail investors can sell the shares after 10 AM on the listing day.
Anthem Biosciences IPO: Listing Date, Lot Size, Price Band
IPO Date |
July 14, 2025 to July 16, 2025 |
Listing Date |
Jul 21, 2025 |
Face Value |
Rs 2 per share |
Price Band |
Rs 540 to Rs 570 per share |
Lot Size |
26 Shares |
Offer for Sale |
5,95,61,404 shares |
Total Issue Size |
5,95,61,404 shares |
Issue Type |
Book-built IPO |
Listing At |
BSE, NSE |
Share Holding Pre-Issue |
55,90,77,100 shares |
Share Holding Post Issue |
55,90,77,100 shares |
Anthem Biosciences Limited: About the Company
Anthem Biosciences Limited, established in 2006 in Bangalore, India, is a major Contract Research and Development Organization (CRDMO).
The company specialises in drug discovery, development, and manufacturing services, catering to large pharmaceutical firms globally. The company has a team of over 1,200 scientists. Anthem offers a various range of services including medicinal chemistry, process development, and analytical research.
Their facilities are equipped with advanced technology and have received approvals from regulatory bodies such as the USFDA and TGA. Anthem has demonstrated strong financial health, characterised by impressive margins and liquidity.
As it continues to expand its capabilities, Anthem remains committed to innovation and quality in the biopharmaceutical sector, ensuring timely delivery and compliance with industry standards.
Anthem Biosciences IPO Objectives
Since the offer is an Offer for Sale, the company will not receive any proceeds from the offer. The funds received from IPO will get directly credited to the bank account of the respective selling shareholders.
Anthem Biosciences IPO: Key Dates, Allotment, Listing Date
IPO Open Date |
July 14, 2025 |
IPO Close Date |
July 16, 2025 |
Basis of Allotment |
July 17, 2025 |
Initiation of Refunds |
July 18, 2025 |
Credit of Shares to Demat |
July 18, 2025 |
Listing Date |
July 21, 2025 |
Cut-off time for UPI mandate |
5 PM on July 16, 2025 |
Anthem Biosciences Financials (Amt in Rs Cr)
Anthem Biosciences Limited posted revenue of Rs 1930.29 crore and a net profit of Rs 451.26 crore for the period ending on March 31, 2024.
Period Ended |
31 Mar 2025 |
31 Mar 2024 |
31 Mar 2023 |
Assets |
2,807.58 |
2,398.11 |
2,014.46 |
Revenue |
1,930.29 |
1,483.07 |
1,133.99 |
Profit After Tax |
451.26 |
367.31 |
385.19 |
EBITDA |
683.78 |
519.96 |
446.05 |
Net Worth |
2,409.86 |
1,924.66 |
1,740.67 |
Reserves and Surplus |
2,298.05 |
1,815.39 |
1,628.88 |
Total Borrowing |
108.95 |
232.53 |
125.06 |
Anthem Biosciences IPO Lot Size Details
Anthem Biosciences IPO lot size is 26 shares. The minimum amount of investment for the retail category is to be around Rs 14,820, and for small HNI, the minimum investment will be around Rs 2,07,480.
Anthem Biosciences IPO Promoter Holdings
Anthem Biosciences promoters are Ajay Bhardwaj, Ganesh Sambasivam, K Ravindra Chandrappa And Ishaan Bhardwaj. The promoters' shareholdings before the IPO were 76.87%; however, after the IPO, shareholdings will decline to 74.68%.
Anthem Biosciences IPO Registrar
Anthem Biosciences IPO registrar is KFin Technologies Limited. On the date of allotment, investors can visit the registrar's website, select the company's name, and enter their PAN number or application ID to check their allotment status.
Anthem Biosciences IPO Lead Managers
Anthem Biosciences IPO lead managers are JM Financial Limited, Citigroup Global Markets India Private Limited, J.P. Morgan India Private Limited, and Nomura Financial Advisory and Securities (India) Private Limited.
How to apply to Anthem Biosciences IPO
Interested investors can apply to the Anthem Biosciences IPO directly from the Bigul trading app by clicking here. Investors can also check the details of other upcoming IPO in Bigul.
Anthem Biosciences IPO FAQ
1. What are the details of the Anthem Biosciences IPO?
Anthem Biosciences IPO is a book-built issue of 5,95,61,404 equity shares amounting to Rs 3,395 crore, entirely an offer for sale.
2. When will the Anthem Biosciences IPO open and close?
Anthem Biosciences IPO's open date is July 14, 2025 and IPO closing date is July 16, 2025.
3. What is Anthem Biosciences IPO GMP?
Anthem Biosciences IPO GMP quotation is Rs 133 per share. You can check the latest GMP price online and reliable GMP once the subscription starts. If the subscription is oversubscribed, then Anthem Biosciences IPO GMP will also rise.
4. Write the details of the IPO Allotment Status.
Anthem Biosciences IPO allotment status is available on July 17, 2025. The listing will be on the BSE and NSE platforms. The registrar of this IPO is KFin Technologies Limited. Investors can check their allotment status after the IPO subscription ends.
5. Who is the registrar and the lead managers for Anthem Biosciences IPO?
Anthem Biosciences IPO registrar is KFin Technologies Limited. On the date of allotment, investors can click on the registrar's website, select the name of the company, and enter their PAN number or application ID to learn their allotment status. The lead manager(s) of JM Financial Limited, Citigroup Global Markets India Private Limited, J.P. Morgan India Private Limited, Nomura Financial Advisory and Securities (India) Private Limited.